Correction: Cutting Edge: Fc RIII (CD16) and Fc RI (CD64) Are Responsible for Anti-Glycoprotein 75 Monoclonal Antibody TA99 Therapy for Experimental Metastatic B16 Melanoma
Albanesi, M., Mancardi, D. A., Macdonald, L. E., Iannascoli, B., Zitvogel, L., Murphy, A. J., Leusen, J. H., Bruhns, P.Volume:
190
Language:
english
Journal:
The Journal of Immunology
DOI:
10.4049/jimmunol.1290083
Date:
February, 2013
File:
PDF, 22 KB
english, 2013